DOCSLIB.ORG

Index to Volume 39 Authorindex

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Index to Volume 39 Authorindex [CANCERRESEARCH39, 5187-5216,December1979] Index to Volume 39 AuthorIndex A Barlock, Green, Huff, Do, Aitken, and Warren, S.Detectionof BothT Cellandla-LikeAntigens 1973 on Cells from Patients with Acute Myelomono Akiba, N. See Sakiyama, Akiba, and Fujimura, cytic Leukemia and Chronic Myelo9enous Leu Abanobi, S. E., Farber, E., and Sarma, D. 5. R. 502 kemia in Blast Crisis, 4810 Persistence of DNA Damage during Develop Aklyama,S-I., Hidaka, K., Komlyama,S., and Anderson, R. F. See Stehlin, Giovanella, de lpolyi, ment of Uver Angiosarcoma in Rats Fed Dimeth Kuwano, M. Control of Permeation of Bleomy and Anderson, 2255'' ylnitrosamine,1592 cin-A2 by Polyene Antibiotics in Cultured Anderson, T. See Murinson, Anderson, Schwartz, Abdo, S. See Schwab,Kollinger,Haas,Ahuja, Chinese Hamster Cells, 5150 Myers, and Chabner, 2471 : Zwelling, Anderson, Abdo, Anders, and Anders, 519 Albert, R. E. See Pereira, Burns, and Albert, 2556 and Kohn, 365 Ab., T. See Matsuda, Osafune, Nakano, Kotake, Aldenderfer, P. H. See Ruddon, Anderson, Anderason, V. See Oskarsson, Andersson, and Sonoda,Watanabe,Hada,Okochi,Higashino, Meade,Aldenderfer,andNeuwald,3885 Tjälve,4175 Yamamura, and Abe, 4694 Alexander, L. See Plunkett, Alexander, Chubb, Andreesen, R. See Modolell, Andreesen, Pahlke, Ablin, R. J. See Bhatti, Ablin, Condoulis, and and Loo, 3655 Brugger, and Munder, 4681 Guinan, 3328 Alexander, R. w. See Richman and Alexander, Angler, R. B. See Wallace, Murdock, Angier, and Abraham,S. SeeHillyardandAbraham,4430 459 Durr, 1570 Abrams, H. L See Young, Hollenberg, Kazam, Alexander,S. S., Jr. SeeKollmorgen,Sansing, Aoki, N. See Nakayasu, Shoji, Aoki, Sato, Miwa, Berkowitz, Halnen, Sandor, and Abrams, 1898 Lehman, Fischer, Longley, Alexander, King, and and Sugimura, 4668 Abul-Hajj, V. J. Effect of Catechol Estrogens on McCay, 3458 Aoyagl, V., Ikenaka, T., and Ichlda, F. a-Fetopro RatMammaryTumors,4882 Allegra, J. C., Llppman, M. E., Thompson, E. B., teinas a CarrierProteinin PlasmaandIts Bill Acoft,K.SeeMalley,Burger,Vandenbark,Frikke, Simon, R., Barlock, A., Green, L, Huff, K. K., rubin-binding Ability, 3571 Flnke,Begley,Acott, Black,and Vetto,619' Do, H. M. T., and Aitken, S. C. Distribution, Apffel, C. A. See Pitha, Kociolek, and Apffel, 170 Adams, J. B., Pwnim, 1., Chandra, D. P., Archl Frequency, and Quantitative Analysis of Estro Apuzzo, M. L. J. See Sheikh, Apuzzo, and Weiss, bald,L, andFee,N. S. A Correlationbetween gen, Progesterone, Androgen, and Glucocorti 1733 Estrogen Sulfotransferase Levels and Estrogen coid Receptors in Human Breast Cancer, 1447 Arai, K., Spencer, J. S., Sohn, N., and Wallace, Receptor Status in Human Primary Breast Car Allegra, J. C., Llppman, M. E., Thompson, E. B., H. W. Effect of Hapten plus Antihapten-Tumor clnoma,5124 Simon, R., Barlock, A., Green, L, Huff, K. K., Serum Treatment on Established Rat Fibrosar Adwis, J. D. See Hoffmann, Adams, Brunne Do, H. M. T., Altken, S. C., and warren, R. coma, 6 mann,andHecht,2505 Relationship between the Progesterone, Andro Arai, K., and Wallace, H. W. Effect of Local Im Adams, P. w. see Mathes, Olsen, Hebebrand, gen, and Glucocorticoid Receptor and Re munotherapy of Syngeneic Rat Fibrosarcoma Hoover, Schaller, Adams, and Nichols, 950 sponse Rate to Endocrine Therapy in Metastatic with Hapten and Antihapten-Tumor Serum upon Adamson, D. J. See Bennett, Smithers, Rose, Breast Cancer, 1973 Nonlocally Treated Tumor, 3638 Adamson, and Thomas, 4868 Allen, C. S. See Hurley, Allen, Feola, and Lubawy, Arai, M. See Cohen, Aral, Jacobs, and Friedell, Adamsan, A. H. See Sieber, Correa, Dalgard, and 3134 1207 Adamson, 4545 Allen, J. A. See Coombs, Kissonerghis, Allen, and Archibald, E. L. See Silver, Karim, Archibald, and Adslstsin, E. H. See Berkelhammer, Caines, Dex Vose, 4160 Salinas, 5036 ter. Adelstein, Oxenhandler, and Hook, 4960 Allpass, P. R. See Costa, Nye, Sunderman, All ArchIbald, L. See Adams, Pewnim, Chandra, Ar Asbersold, P. M. Mutation Induction by 5-Fluoro pass, and Gondos, 3591 chibald, and Foo, 5124 deoxyuridlne in Synchronous Chinese Hamster Amaki, I. See Horikoshi, Sasaki, Mizo9uchi, Arendes, J. See MUller, Maidhof, Arendes, Geurt Cells, 808 Miura, Takaku, and Amaki, 1841 sen. Zahn, and Schmidseder, 3768 Agarwal, R. P. Recovery of 2'-Deoxycoformycin Ambrose, w. w. See Hanker, Ambrose, James, Arima, 1. See Niinobe, Tamura, Arima, and Fujii, inhIbited Adenosine Deaminaseof Mouse Eryth Mandelkorn, Yates, Gall, Bossen, Fay, Laszlo, 4212 rocytes and Leukemia Li 210 in Vivo, i 425, and Moore, 1635 Artaza, L. See Seraydarian and Artaza, 2940 Communication Ames, M. M. See Kovach, Ames, Powis, Moertel, Arthur, L 0. See Tagliabue, Herberman, Arthur, Agarwal, S. See Vaage and Agarwal, 1511 Hahn, and Creagan, 4540; Kovach, Ames, Ster and McCoy, 35 Aglietta, M. and Colly, L. Relevance of Recruit nad, and O'Connell, 823: Powis, Ames, and Asch, B. B., Medina, D., and Brinkley, B. R. ment-Synchronization in the Scheduling of 1-/@- Kovach, 3564 Microtubules and Actin-containing Filaments of D-Arablnofuranosylcytosinein a Slow-growing Ames, M. M., Powis, G., Kovach, J. S., and Normal, Preneoplastic, and Neoplastic Mouse Acute Myeloid Leukemia of the Rat, 2727 Eagan, R. T. Disposition and Metabolism of Mammary Epithelial Cells, 893 Ahmsd, A. See Malenka, Rogan, Howe, Nelson, Pentamethylmelamine and Hexamethylmela Ashley, M. P. See Zbar, Canti, Ashley, Rapp, Wrobel, Ahmed, and Humphreys, 4782 minein RabbitsandHumans,5016 Hunter, and Ribi, 1597 Ahmd, F. E., and Setlow, R. B. DNA Repair in Ames, R. S., Jr. See Ng, Ames,Mclntire,and Ashman, L K., Cook, M. 0., and Kotlareki, I. Xeroderma Pigmentosum Cells Treated with Herberman, 4887 Protective Effect of Oral Salmonella enteritidis Combinations of ultraviolet Radiation and N- Anders, A. See Schwab, Kollinger, Hass, Ahuja, 11Rx Infection against Colon Tumor Induction Acetoxy-2-acetylaminofluorene, 471 Abdo, Anders, and Anders, 519 by 1,2-Dimethylhydrazine in Mice, 2768 Ahmsd, N. K., and Welch, A. D. Some Properties Anders, F. See Schwab, Kollinger, Haas, Ahuja, Ashworth, L. K. See Carrano, MayaII,Testa, Ash of Uridine-Cytidine Kinase from a Human Malig Abdo, Anders, and Anders, 519 worth, and Rowley, 2984 nant Lymphoma, 3102 Anderson, A. K. See Paterson, Anderson, Smith, Asp, N-G. See Bauer, Asp, Oste, Dahlqvist, and Ahuja, M. R. See Schwab, Kollinger, Haas, Ahuja, and Smith, 3725 Fredlund, 3752 Abdo, Anders, and Anders, 519 Anderson, C. See Ruddon, Anderson, Meade, AtkInson, E. R. Assessment of Current Hyper Aitlo, M-L. See Yamashita, Aitio, and Dawson, Aldenderfer, and Neuwald, 3885 thermia Technology, 2313― 1780 Anderson, 0. J. Delivery of Essential Services to Au, J. L., and Sadee, W. 5-Fluorouracil Concen @ Altken, S. C. See Allegra, Lippman, Thompson, Alcoholics through the ‘Continuumof Care,― trations in Human Plasma following R,S-1-(let Simon, Barlock, Green, Huff, Do, and Altken, 2855― rahydro-2-furanyl)-5-fluorouracil (Ftorafur) Ad 1447; Allegra, Lippman, Thompson, Simon, Anderson, J. K., Moore, J. 0., and Metzgar, R. ministration, 4289, Letter to the Editor Auchlncloss, J. H. See Comis, Kuppinger, Gins berg, Crooke, Gilbert, Auchincloss, and Pres aFebruarysymposiumissue,‘‘InternationalWorkshopon LeukocyteAd tayko, 5076 herence Inhibition.― Audy-Jurkovk@,S. See Pavelió,Slijep@evic,Pay aSJunesymposiumIssue,‘‘Conferenceon HyperthermiainCancerTreat eli& Ivic, Audy-Jurkoviá,Pavelic, and Boranic, ment.― 1807 aae Julysymposiumissue,‘‘AlcoholandCancerWorkshop.― Aune, T. See Dybing, von Bahr, Aune, Glaumann, DECEMBER1979 5187 Author Index to Volume 39 Levitt, and Thorgeirsson, 4206 Barlock, Green, Huff, Do, Aitken, and Warren, Mullen, Brown, and Spomn,1339: Thompson, Austin,F. C. SeeOikawa,Gotohda,Austin,Tak 1973 Becci, Brown, and Moon, 3977 eichi, and Boone, 3519 Barlogle, B. See Bergerat, Barlogie, and Dre Beccl, P. J., Thompson, H. J., Grubbs, C. J., Austin,R.L.SeeParmley,DahI,Austin,Gauthier, winko, 1334: Bergerat, Barlogie, Göhde,John Brown, C. C., and Moon, R. C. Effect of Delay and Denys, 3834 ston, and Drewinko, 4356; Drewinko, Barlogie, in Administration of 13-cis-Retinoic Acid on the Autrup, H. See Harris, Autrup, Stoner, Trump, and Freireich, 2630: Spitzer, Verma, Barlogie, Inhibition of Urinary Bladder Carcinogenesis in Hillman, Schafer, and Jeffrey, 4401 Beran, and Dicke, 3215 theRat,3141 Autrup, H., Essigmann, J. N., Croy, R.G., Trump, Barlogle, B., Corry, P. M., Yip, E., Llppman, 1., Beck, W. S. See Thomndike,Pelliniemi, and Beck, B. F., Wogan,G. N., and Harris,C. C. Metab Johnston, D. A., KhaIll, K., Tenczynskl, 1. F., 3435 olism of Aflatoxin B, and Identification of the Reilly, E., Lawson, R., Dosik, G., Rigor, B., Beck, W. T., Mueller, T. J., and Tanzer, L R. Major Aflatoxin B,-DNA Adducts Formed in Cul Hankenson, R., and Freireich, E. J Total-Body Altered Surface Membrane Glycoproteins In tured Human Bronchus and Colon, 694 Hyperthermia with and without Chemotherapy Vinca Alkaloid-resistant Human Leukemic Lym Axelrod, J. See Hoffman, Paul, and Axelrod, 4584 for Advanced Human Neoplasms, 1481 phoblasts, 2070 Axeirod, R. S. See Holroyde, Axelrod, Skutches, Barlow, J. J. See Chatterjee, Bhattacharya, and Becker, F. F. Lack of Proportionality between Haff, Paul, and Reichard, 4900 Barlow, 1943 Rate of Cell Division and Induction of Tumors in Aylsworth, C. F., Hodson, C. A., Berg, G., KIed Barna, B. P., and Deodhar, S. D. Immunological Carcinogen-exposed Regenerating Livers, zik, G., and Meites,J. Roleof Adrenalsand Activity of Regional Lymph Nodes in Tumor 5177, Letter to the Editor. See also Hudig, Sell, Estrogen in Regression of Mammary Tumors bearing Mice, 2711 Newell, and Becker, 3715: Liau, Chang, and during Postpartum Lactation in the Rat, 2436 Barney, C. See Tong, Burger, Finke, Barney, Van Becker, 2113: Stout and Becker, 1168 Azarnoff, 0. L. See Reddy, Rao, Azarnoff, and denbark,and Vetto,597 Becker, F. F., and Soil, S. Differences in Serum Sell, 152; Svoboda and Azarnoff, 3419 Barone, R. M. See Belnap, Cleveland, Colmer a-Fetoprotein Concentrations during the Carci Azlzkhan, J. C., Speeg, K. V., Jr., Stromberg, K., auer, Barone, and Pilch, 1174 nogenic Sequences Resulting from Exposure to andGoode,D.Stimulationof HumanChorionic Barra, R., Parsons, J., Koch, M.
Load more

Recommended publications
  • COMBINED LIST of Particularly Hazardous Substances
    COMBINED LIST of Particularly Hazardous Substances revised 2/4/2021 IARC list 1 are Carcinogenic to humans list compiled by Hector Acuna, UCSB IARC list Group 2A Probably carcinogenic to humans IARC list Group 2B Possibly carcinogenic to humans If any of the chemicals listed below are used in your research then complete a Standard Operating Procedure (SOP) for the product as described in the Chemical Hygiene Plan. Prop 65 known to cause cancer or reproductive toxicity Material(s) not on the list does not preclude one from completing an SOP. Other extremely toxic chemicals KNOWN Carcinogens from National Toxicology Program (NTP) or other high hazards will require the development of an SOP. Red= added in 2020 or status change Reasonably Anticipated NTP EPA Haz list COMBINED LIST of Particularly Hazardous Substances CAS Source from where the material is listed. 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide Acutely Toxic Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- Acutely Toxic 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) Prop 65 KNOWN Carcinogens NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) IARC list Group 2A Reasonably Anticipated NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) Prop 65 1-(o-Chlorophenyl)thiourea Acutely Toxic 1,1,1,2-Tetrachloroethane IARC list Group 2B 1,1,2,2-Tetrachloroethane Prop 65 IARC list Group 2B 1,1-Dichloro-2,2-bis(p -chloropheny)ethylene (DDE) Prop 65 1,1-Dichloroethane
    [Show full text]
  • Chemical Hygiene Plan Manual
    CHEMICAL HYGIENE PLAN AND HAZARDOUS MATERIALS SAFETY MANUAL FOR LABORATORIES This is the Chemical Hygiene Plan specific to the following areas: Laboratory name or room number(s): ___________________________________ Building: __________________________________________________________ Supervisor: _______________________________________________________ Department: _______________________________________________________ Telephone numbers 911 for Emergency and urgent consultation 48221 Police business line 46919 Fire Dept business line 46371 Radiological and Environmental Management Revisied on: Enter a revision date here. All laboratory chemical use areas must maintain a work-area specific Chemical Hygiene Plan which conforms to the requirements of the OSHA Laboraotry Standard 29 CFR 19190.1450. Purdue University laboratories may use this document as a starting point for creating their work area specific CHP. Minimally this cover page is to be edited for work area specificity (non-West Lafayette laboratories are to place their own emergency, fire, and police telephone numbers in the space above) AND appendix K must be completed. This instruction and information box should remain. This model CHP is version 2010A; updates are to be found at www.purdue.edu/rem This page intentionally blank. PURDUE CHEMICAL HYGIENE PLAN AWARENESS CERTIFICATION For CHP of: ______________________________ Professor, building, rooms The Occupational Safety and Health Administration (OSHA) requires that laboratory employees be made aware of the Chemical Hygiene Plan at their place of employment (29 CFR 1910.1450). The Purdue University Chemical Hygiene Plan and Hazardous Materials Safety Manual serves as the written Chemical Hygiene Plan (CHP) for laboratories using chemicals at Purdue University. The CHP is a regular, continuing effort, not a standby or short term activity. Departments, divisions, sections, or other work units engaged in laboratory work whose hazards are not sufficiently covered in this written manual must customize it by adding their own sections as appropriate (e.g.
    [Show full text]
  • Biochemical and Pathological Effects of Methylazoxymethanol Acetate, a Potent Carcinogen1
    [CANCER RESEARCH 30, 801-812, March 1970] Biochemical and Pathological Effects of Methylazoxymethanol Acetate, a Potent Carcinogen1 Morris S. Zedeck, Stephen S. Sternberg, Richard W. Poynter, and Jane McGowan Divisions of Pharmacology and Cytology, Sloan-Kettering Institute for Cancer Research, New York, New York 10021 SUMMARY vealed that the agent is cleaved by the intestinal flora which possess a 0-o-glucosidase, and that the free agly Methylazoxymethanol acetate is known to induce tu cone methylazoxymethanol is the active carcinogen (13- mors in rodents. Effects produced by a single nonlethal 15, 34). Matsumoto et al. (19) synthesized MAM acetate3 dose on nucleic acid and protein synthesis have been in (Chart 1), which is stable and not dependent upon vestigated in rat and mouse liver, small intestine, and ,0-glucosidase cleavage for activity. Single or only a few kidney, the 3 organs most susceptible to carcinogenesis. doses of cycasin, or of the aglycone methylazoxymetha The agent induced early inhibition of thymidine incor nol, are required to induce tumors in rats which are pri poration into DNA of rat tissues. Rat liver was most sen marily of the kidney, intestinal tract, and liver (11, 15). sitive to this effect and was the only organ to show marked Aqueous extracts of cycad nut have also been shown to inhibition of RNA and protein synthesis. In mice, liver induce tumors of liver and kidneys in mice (21). The was more sensitive than small intestine or kidney and ex present investigation was undertaken to study the acute hibited an inhibition of RNA and protein synthesis; there pathological and biochemical effects produced by MAM were no changes observed in small intestine or kidney.
    [Show full text]
  • Carbon Tetrachloride
    CARBON TETRACHLORIDE Data were last reviewed in IARC (1979) and the compound was classified in IARC Monographs Supplement 7 (1987a). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 56-23-5 Chem. Abstr. Name: Tetrachloromethane IUPAC Systematic Name: Carbon tetrachloride Synonyms: Benzinoform; carbona 1.1.2 Structural and molecular formulae and relative molecular mass Cl Cl CCl Cl CCl4 Relative molecular mass: 153.82 1.1.3 Chemical and physical properties of the pure substance (a) Description: Colourless, clear, nonflammable, liquid with a characteristic odour (Budavari, 1996) (b) Boiling-point: 76.8°C (Lide, 1997) (c) Melting-point: –23°C (Lide, 1997) (d) Solubility: Very slightly soluble in water (0.05% by volume); miscible with benzene, chloroform, diethyl ether, carbon disulfide and ethanol (Budavari, 1996) (e) Vapour pressure: 12 kPa at 20°C; relative vapour density (air = 1), 5.3 at the boiling-point (American Conference of Governmental Industrial Hygienists, 1991) (f) Conversion factor: mg/m3 = 6.3 × ppm 1.2 Production and use Production in the United States in 1991 was reported to be approximately 143 thousand tonnes (United States International Trade Commission, 1993). Information –401– 402 IARC MONOGRAPHS VOLUME 71 available in 1995 indicated that carbon tetrachloride was produced in 24 countries (Che- mical Information Services, 1995). Carbon tetrachloride is used in the synthesis of chlorinated organic compounds, including chlorofluorocarbon refrigerants. It is also used as an agricultural fumigant and as a solvent in the production of semiconductors, in the processing of fats, oils and rubber and in laboratory applications (Lewis, 1993; Kauppinen et al., 1998).
    [Show full text]
  • 2019 Minnesota Chemicals of High Concern List
    Minnesota Department of Health, Chemicals of High Concern List, 2019 Persistent, Bioaccumulative, Toxic (PBT) or very Persistent, very High Production CAS Bioaccumulative Use Example(s) and/or Volume (HPV) Number Chemical Name Health Endpoint(s) (vPvB) Source(s) Chemical Class Chemical1 Maine (CA Prop 65; IARC; IRIS; NTP Wood and textiles finishes, Cancer, Respiratory 11th ROC); WA Appen1; WA CHCC; disinfection, tissue 50-00-0 Formaldehyde x system, Eye irritant Minnesota HRV; Minnesota RAA preservative Gastrointestinal Minnesota HRL Contaminant 50-00-0 Formaldehyde (in water) system EU Category 1 Endocrine disruptor pesticide 50-29-3 DDT, technical, p,p'DDT Endocrine system Maine (CA Prop 65; IARC; IRIS; NTP PAH (chem-class) 11th ROC; OSPAR Chemicals of Concern; EuC Endocrine Disruptor Cancer, Endocrine Priority List; EPA Final PBT Rule for 50-32-8 Benzo(a)pyrene x x system TRI; EPA Priority PBT); Oregon P3 List; WA Appen1; Minnesota HRV WA Appen1; Minnesota HRL Dyes and diaminophenol mfg, wood preservation, 51-28-5 2,4-Dinitrophenol Eyes pesticide, pharmaceutical Maine (CA Prop 65; IARC; NTP 11th Preparation of amino resins, 51-79-6 Urethane (Ethyl carbamate) Cancer, Development ROC); WA Appen1 solubilizer, chemical intermediate Maine (CA Prop 65; IARC; IRIS; NTP Research; PAH (chem-class) 11th ROC; EPA Final PBT Rule for 53-70-3 Dibenzo(a,h)anthracene Cancer x TRI; WA PBT List; OSPAR Chemicals of Concern); WA Appen1; Oregon P3 List Maine (CA Prop 65; NTP 11th ROC); Research 53-96-3 2-Acetylaminofluorene Cancer WA Appen1 Maine (CA Prop 65; IARC; IRIS; NTP Lubricant, antioxidant, 55-18-5 N-Nitrosodiethylamine Cancer 11th ROC); WA Appen1 plastics stabilizer Maine (CA Prop 65; IRIS; NTP 11th Pesticide (EPA reg.
    [Show full text]
  • Carcinogens CAS DOT SHHC Sources Number Chemical Name
    2010 Right to Know Special Health Hazardous Substance List Substance Common Name Carcinogens CAS DOT SHHC Sources Number Chemical Name 3140 # ACEPHATE 30560-19-1 2783 CA 3 6 8 17 18 PHOSPHORAMIDOTHIOIC ACID, ACETYL-, O,S-DIMETHYL ESTER 0001 # ACETALDEHYDE 75-07-0 1089 CA MU TE F4 1 2 3 4 5 6 7 8 R2 15 17 18 20 21 ACETALDEHYDE 22 2890 # ACETAMIDE 60-35-5 3077 CA 3 6 7 17 18 20 ACETAMIDE 0010 # 2-ACETYLAMINOFLUORENE 53-96-3 CA MU 1 4 5 6 18 20 21 ACETAMIDE, N-9H-FLUOREN-2-YL- 0022 # ACRYLAMIDE 79-06-1 2074 CA R2 1 2 3 4 5 6 7 8 15 17 18 19 20 2-PROPENAMIDE 21 0024 # ACRYLONITRILE 107-13-1 1093 CA TE F3 R2 1 2 3 4 5 6 7 8 14 15 17 18 19 2-PROPENENITRILE 20 21 22 3142 # AF- 2 3688-53-7 CA 7 2-FURANACETAMIDE, .alpha.-[(5-NITRO-2-FURANYL)METHYLENE]- 0029 # AFLATOXINS 1402-68-2 CA MU TE 5 7 AFLATOXINS 0033 # ALDRIN 309-00-2 2761 CA TE 1 2 3 4 6 7 8 14 17 18 19 20 21 1,4:5,8-DIMETHANONAPHTHALENE, 1,2,3,4,10,10-HEXACHLORO-1,4,4a,5,8,8aHEXAHYDRO(1R,4S,4aS,5S,8R,8aR)-rel- Page 1 of 55 2010 Right to Know Special Health Hazardous Substance List Substance Common Name Carcinogens CAS DOT SHHC Sources Number Chemical Name 0039 # ALLYL CHLORIDE 107-05-1 1100 CA F3 1 2 3 4 6 7 8 15 17 18 20 1-PROPENE, 3-CHLORO- 0069 # 2-AMINOANTHRAQUINONE 117-79-3 CA MU 5 6 7 18 9,10-ANTHRACENEDIONE, 2-AMINO- 4012 # 1-AMINO-2,4-DIBROMOANTHRAQUINONE 81-49-2 CA 5 9,10-ANTHRACENEDIONE, 1-AMINO-2,4-DIBROMO- 0072 # 4-AMINODIPHENYL 92-67-1 CA MU 1 2 4 5 6 7 18 20 [1,1'-BIPHENYL]-4-AMINE 0076 # 1-AMINO-2-METHYLANTHRAQUINONE 82-28-0 CA 5 6 7 18 9,10-ANTHRACENEDIONE, 1-AMINO-2-METHYL-
    [Show full text]
  • Carcinogens, Reproductive Toxins, and Teratogens
    Environmental Health and Safety 2408 Wanda Daley Drive Ames, Iowa 50011-3602 Phone (515) 294-5359 www.ehs.iastate.edu Carcinogens, Reproductive Toxins, and Teratogens The materials on this list pose a significant risk of exposure or damage to the human body and require special procedures be developed for their safe use. Refer to page four of the Laboratory Safety Manual for more information. Materials involving industrial processes or manufacturing conditions which are not generally present at Iowa State University may have been omitted from this list. To ensure the current status of a chemical, check with the coordinating agency at the locations footnoted, a current safety data sheet (SDS) or call Environmental Health and Safety (EH&S) at (515) 294-5359. OSHA – Occupational Safety and Health Administration1 X – regulated carcinogen IARC – International Agency for Research on Cancer2 1 – known human carcinogen 2A – probable human carcinogen 2B – possible human carcinogen NTP – National Toxicology Program3 K – known carcinogen A – reasonably anticipated to be a carcinogen Repro Toxin – Reproductive Toxin X – material considered by one or more footnoted references to be harmful to adult reproductive systems Tera – Teratogen X – material considered by one or more footnoted references to cause birth defects in off-spring Repro SUBSTANCE OSHA IARC NTP Tera Toxin A-a-C (2-Amino-9H-pyrido[2,3-b]indole) 2B Acetaldehyde 2B A X Acetamide 2B 2-Acetylaminofluorene X A Page 1 of 32 Repro SUBSTANCE OSHA IARC NTP Tera Toxin Acheson process, occupational
    [Show full text]
  • Particularly Hazardous Substances (Phs)
    PARTICULARLY HAZARDOUS SUBSTANCES (PHS) This list contains examples of chemicals that may be used at the University of Nebraska Medical Center (UNMC). The list is not all-inclusive. This lists contains examples of Particularly Hazardous Substances (PHS) which are a special subset of OSHA Hazardous Chemicals. PHS include chemicals that are known or suspect carcinogens, reproductive toxins, and/or highly toxic materials. Before working with any PHS, please determine if you have any of these and evaluate if additional protective work practices are needed. You should utilize the PHS Assessment Form to help in this evaluation. Abbreviations Used in List Headings CARC NTP National Toxicology Program listed carcinogen - National Toxicology Program K = known carcinogen S = suspect carcinogen CARC IARC International Association for Research on Cancer listed carcinogen - IARC 1= known human carcinogen 2A = probable human carcinogen 2B = possible human carcinogen CARC OSHA OSHA regulated carcinogen - OSHA-regulated carcinogens X = regulated carcinogen REPRO SHEP Included in Catalog of Teratogenic Agents, T.H. Shepard, 6th Edition, Johns Hopkins Press, 1989 X = listed teratogen REPRO CALIF Listed by the State of California ‘Safe Drinking Water Act, 1986’ http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html F = female reproductive hazard M = male reproductive hazard HTX Highly toxic, included in EPA’s list ‘Acutely Toxic Hazardous Waste’, P-listed waste 40 CFR 261.33, or Included in OSHA’s list of highly hazardous chemicals with a threshold £200
    [Show full text]
  • Multi-Dimensional Mycelia Interactions
    Multi-dimensional mycelia interactions A thesis submitted to Cardiff University for the degree of Doctor of Philosophy By Jade O’Leary, B.Sc (Hons) February 2018 DECLARATION This work has not been submitted in substance for any other degree or award at this or any other university or place of learning, nor is being submitted concurrently in candidature for any degree or other award. Signed ………………………………………… (candidate) Date ………………………… STATEMENT 1 This thesis is being submitted in partial fulfilment of the requirements for the degree of PhD. Signed ………………………………………… (candidate) Date ………………………… STATEMENT 2 This thesis is the result of my own independent work/investigation, except where otherwise stated. Other sources are acknowledged by explicit references. The views expressed are my own. Signed ………………………………………… (candidate) Date ………………………… STATEMENT 3 I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter- library loan, and for the title and summary to be made available to outside organisations. Signed ………………………………………… (candidate) Date ………………………… STATEMENT 4: PREVIOUSLY APPROVED BAR ON ACCESS I hereby give consent for my thesis, if accepted, to be available for photocopying and for inter- library loans after expiry of a bar on access previously approved by the Academic Standards & Quality Committee. Signed ………………………………………… (candidate) Date ………………………… i Acknowledgements I would like to thank my supervisors, Dr Carsten Müller and Professor Dan Eastwood for all their time and advice, and especially Professor Lynne Boddy for her tireless dedication and infectious enthusiasm. Thanks to the Natural Environment Research Council (NERC) for studentship NE/L00243/1 and for funding UHPLC-MS analyses at the NERC Biomolecular Analysis Facility, Birmingham (NBAF-B).
    [Show full text]
  • Chemical Hygiene Plan
    Chemical Hygiene Plan Document Number: EHS-DOC600.02 Chemical Hygiene Plan Table of Contents 1.0 BACKGROUND ......................................................................................................................... 5 1.1 REGULATORY STANDARDS .............................................................................................................. 5 1.2 FLORIDA INTERNATIONAL UNIVERSITY LABORATORY SAFETY STANDARD OPERATING PROCEDURES ............................................................................................................................................... 5 1.3 PLAN DEVELOPMENT, MAINTENANCE, AND REVISION .................................................................. 6 2.0 INTRODUCTION ....................................................................................................................... 7 2.1 PURPOSE ......................................................................................................................................... 7 2.2 SCOPE .............................................................................................................................................. 7 2.3 PROGRAM ADMINISTRATION RESPONSIBILITY AND ACCOUNTABILITY ......................................... 8 2.4 GENERAL LABORATORY SAFETY CONCEPTS .................................................................................. 10 3.0 HEALTH AND SAFETY TRAINING REQUIREMENTS .................................................................... 15 3.1 EMPLOYEE RIGHT-TO-KNOW STANDARD ....................................................................................
    [Show full text]
  • List of Extremely Hazardous Substances
    Chemical Name CAS Number Hazard A A-alpha-C (2-Amino-9H-pyrido{2,3-b]indole) 26148 -68-5 Carcinogen Acetaldehyde 76-07-0 Carcinogen, Reproductive Toxin Acetamide 60-35-5 Carcinogen Acetochlor 34256-82-1 Carcinogen 2-Acetylaminofluorene 53-96-3 Carcinogen Acifluorfen 62476-59-9 Carcinogen Acrolein 107-02-8 High acute toxicity Acrylamide 79-06-1 Carcinogen Acrylonitrile 107-13-1 Carcinogen Actinomycin D 50-76-0 Carcinogen Adriamycin (Doxorubicin hydrochloride) 23214-92-8 Carcinogen AF-2; [2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide 3588-53-7 Carcinogen Aflatoxins ---- Carcinogen, Reproductive Toxin Alachlor 15972-60-8 Carcinogen Aldrin 309-00-2 Carcinogen Allyl chloride 107-05-1 Carcinogen Aluminum chloride 7446-70-0 Reproductive Toxin 2-Aminoanthraquinone 117-79-3 Carcinogen p-Aminoazobenzene 60-09-3 Carcinogen ortho-Aminoazotoluene 97-56-3 Carcinogen 4-Aminobiphenyl (4-aminodiphenyl) 92-67-1 Carcinogen 3-Amino-9-ethylcarbazole hydrochloride 6109-97-3 Carcinogen 1-Amino-2-methylanthraquinone 82-28-0 Carcinogen 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole 712-68-5 Carcinogen 2-Aminopyridine 462-08-8 High acute toxicity Amitrole 61-82-5 Carcinogen Anesthetic gases --- Reproductive Toxin ortho-Anisidine 90-04-0 Carcinogen ortho-Anisidine hydrochloride 134-29-2 Carcinogen Antimony oxide (Antimony trioxide) 130-96-4 Carcinogen Aramite 140-57-8 Carcinogen Arsenic (inorganic arsenic compounds) --- Carcinogen Arsenic 7440-38-2 Reproductive Toxin Arsenic pentafluoride gas 784-36-3 High Acute Toxicity Arsine gas 7784-42-1 High Acute Toxicity Asbestos
    [Show full text]
  • Particularly Hazardous Chemicals Which Include Carcinogens, Mutagens, Reproductive Hazards and Acutely Toxic Chemicals
    Particularly Hazardous Chemical List OSHA requires that written standard operating procedures be available for all research using particularly hazardous chemicals which include carcinogens, mutagens, reproductive hazards and acutely toxic chemicals. SOP should include procedures for; establishing a designated area, safe storage, use and handling, waste collection and disposal, and decontamination. Note: This list of carcinogens, reproductive toxins, biotoxins and acutely toxic substances is not exhaustive Chemical Source 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl- IARC-1/NTP CCNU; Semustine) [13909-09-6] 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) IARC-2A/NTP (Lomustine) 1-(o-Chlorophenyl)thiourea AcutelyHazardousWaste 1,1-Dimethylhydrazine [57-14-7] IARC-2B/NTP 1,2,3-Propanetriol, trinitrate AcutelyHazardousWaste 1,2,3-Trichloropropane IARC-2A/NTP 1,2-Benzenediol, 4-[l-hydroxy-2-(methylamino)- ethyl]- AcutelyHazardousWaste 1,2-Dibromo-3-chloropropane (DBCP) IARC-2B/NTP/OSHA 1,2-Dibromoethane (Ethylene Dibromide) NTP 1,2-Dichloroethane (Ethylene Dichloride) IARC-2B/NTP 1,2-Diethylhydrazine [1615-80-1] IARC-2B 1,2-Dimethylhydrazine [540-73-8] IARC-2A 1,2-Epoxybutane [106-88-7] IARC-2B 1,2-Propylenimine AcutelyHazardousWaste 1,3-Butadiene IARC-2A/NTP/OSHA 1,3-Dichloropropene (Technical Grade) IARC-2B/NTP 1,3-Propane Sultone IARC-2B/NTP 1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10- hexachloro- 1,4,4a,5,8,8a hexahydro-, AcutelyHazardousWaste (1alpha,4alpha,4abeta,5alpha,8alpha,8abeta)- 1,4,5,8-Dimethanonaphthalene,
    [Show full text]